GSA Capital Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,463
Closed -$103K 1632
2025
Q3
$103K Buy
+11,463
New +$106K 0.01% 1521
2024
Q3
Sell
-21,743
Closed -$217K 1556
2024
Q2
$217K Buy
+21,743
New +$221K 0.02% 1429
2023
Q4
Sell
-56,043
Closed -$510K 1455
2023
Q3
$510K Buy
+56,043
New +$672K 0.04% 782
2023
Q2
Sell
-43,000
Closed -$534K 1476
2023
Q1
$534K Buy
+43,000
New +$791K 0.05% 670
2022
Q4
Sell
-32,497
Closed -$610K 1415
2022
Q3
$610K Buy
+32,497
New +$668K 0.08% 428

Other funds holding AHCO

GSA Capital Partners's AHCO Position: Q4 2025 in Review

GSA Capital Partners sold out of AdaptHealth (AHCO) in Q4 2025, closing a stake of 11,463 shares — an estimated $103K sold.

GSA Capital Partners first reported a position in AHCO in Q3 2022 and held it in 5 quarters. The position peaked at $610K in Q3 2022. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

  • GSA Capital Partners reported no remaining AdaptHealth position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 11,463 AdaptHealth shares in Q4 2025, an estimated $103K.
  • GSA Capital Partners first reported a position in AdaptHealth in Q3 2022 and held it in 5 quarters.
  • GSA Capital Partners's AdaptHealth position peaked at $610K in Q3 2022.
  • 231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.